Abstract:Summary: Deep brain stimulation (DBS) has been used to treat various tremor disorders for several decades. Medicationresistant, disabling essential tremor (ET) is the most common tremor disorder treated with DBS. The treatment has been consistently reported to result in significant benefit in upper extremity, as well as head and voice tremor, all of which were improved more dramatically with bilateral procedures. These benefits have been demonstrated to be sustained for up to 7 years. DBS has also been shown t… Show more
“…This functional disability is due not only to the physical limitations the tremor itself induces but also to the social embarrassment and withdrawal these patients suffer. The safety and efficacy of stimulation of the VIM are well documented in the literature [20,21,22,23] and, although thalamotomy and DBS may provide comparable improvement of the condition, adverse effects (such as dysarthria, cognitive deterioration and gait disturbances) are generally more common with ablative procedures [24]. Our data corroborates that VIM DBS improves tremor and performance in a variety of daily living even several years after implantation.…”
Background: Deep brain stimulation (DBS) is a standard treatment for patients with disabling essential tremor. The short-term efficacy rate is well established. Objectives: To assess the long-term effects of DBS in our series and evaluate the durability of the effects over time. Methods: Eighty-four patients implanted with unilateral or bilateral DBS for essential tremor were asked to complete three mailed-in questionnaires to assess DBS efficacy objectively and subjectively. Results: Twenty-six patients responded, with a median follow-up of 41 months. Approximately half of the patients had more than 48 months of follow-up. At the time of follow-up, the Tremor Rating Scale was reduced from a mean score of 7 (5–8) to 3 (2–3) with DBS OFF and ON, respectively. Quality of life, measured with a subset of items of the ADL Taxonomy, improved from a mean of 26 (23–33) to 12 (12–14), comparing DBS OFF and ON. No significant differences were seen when comparing efficacy at short- (<12 months), middle- (12–48 months) or long-term (>48 months) follow-ups. Conclusion: DBS has long-term efficacy for tremor control. This is associated with sustained benefits in quality of life. The duration of the follow-up was not associated with any significant difference in efficacy.
“…This functional disability is due not only to the physical limitations the tremor itself induces but also to the social embarrassment and withdrawal these patients suffer. The safety and efficacy of stimulation of the VIM are well documented in the literature [20,21,22,23] and, although thalamotomy and DBS may provide comparable improvement of the condition, adverse effects (such as dysarthria, cognitive deterioration and gait disturbances) are generally more common with ablative procedures [24]. Our data corroborates that VIM DBS improves tremor and performance in a variety of daily living even several years after implantation.…”
Background: Deep brain stimulation (DBS) is a standard treatment for patients with disabling essential tremor. The short-term efficacy rate is well established. Objectives: To assess the long-term effects of DBS in our series and evaluate the durability of the effects over time. Methods: Eighty-four patients implanted with unilateral or bilateral DBS for essential tremor were asked to complete three mailed-in questionnaires to assess DBS efficacy objectively and subjectively. Results: Twenty-six patients responded, with a median follow-up of 41 months. Approximately half of the patients had more than 48 months of follow-up. At the time of follow-up, the Tremor Rating Scale was reduced from a mean score of 7 (5–8) to 3 (2–3) with DBS OFF and ON, respectively. Quality of life, measured with a subset of items of the ADL Taxonomy, improved from a mean of 26 (23–33) to 12 (12–14), comparing DBS OFF and ON. No significant differences were seen when comparing efficacy at short- (<12 months), middle- (12–48 months) or long-term (>48 months) follow-ups. Conclusion: DBS has long-term efficacy for tremor control. This is associated with sustained benefits in quality of life. The duration of the follow-up was not associated with any significant difference in efficacy.
“…The emergence of increased bilateral coupling within the MS group may indicate that this disease process affects the neurological structures underlying tremorgenesis. Given that approximately 80% of MS patients have lesions within the brainstem or cerebellum [17], and these same structures are also believed to play a role in tremor production [36,37], it is possible that the progressive decline in function within these central neural sites could be a factor in the development of increased coupling.…”
Section: Differences In Tremor Due To Msmentioning
confidence: 99%
“…The majority of treatment options discussed in the literature specific to MS include neurosurgery [12,45] and brain stimulation techniques in advanced cases [17,46,47]. However, there is evidence that less invasive treatment such as exercise could mitigate tremor abnormalities in other populations, as resistance training has been found to decrease tremor amplitude in older adults [48,49] and in persons with ET [50].…”
Section: Differences In Tremor Due To Msmentioning
confidence: 99%
“…Enhanced tremor is a common manifestation of this central nervous system damage, being reported in 25-60% of MS cases, with the two most prevalent forms being intention tremor and postural tremor [15][16][17][18]. Although tremor is a prevalent motor symptom for a sizable proportion of individuals with MS, the majority of research has been restricted to simply assessing changes in amplitude [19,20].…”
“…Improvement has been reported with botulinum toxin A injections, in particular in palatal and writing tremor [18]. In severe cases, functional neurosurgery may be useful [30]. …”
Section: Clinical Features Of Poststroke Movement Disordersmentioning
Although rare, many different types of hyperkinetic and hypokinetic movement disorders have been described after both ischemic and hemorrhagic stroke in children and in adults. Current knowledge about these disorders comes from single case reports or small series of cases compiled from retrospective studies. Data from hospital-based studies suggest a prevalence of poststroke movement disorders ranging from 1.1 to 3.9%. However, despite the development of emergency care for stroke, these clinical syndromes remain insufficiently recognized. Poststroke movement disorders take place in the acute phase or following a variable delay after stroke onset, and could be transient or persistent. Dystonia is the most frequent movement disorder, occurring after a delay of several months, while chorea and hemiballism are most frequent in the acute stages. Amongst transient movement disorders, limb shaking is associated with high-grade stenosis or occlusion of the internal carotid artery, while myoclonus and asterixis are rare. From a pathophysiological point of view, most of these symptoms are induced by a lesion involving the basal ganglia, the thalamus, or the frontal subcortical pathways. In this article, we updated the clinical spectrum, neuropathophysiological mechanisms, and prognosis of stroke-induced movement disorders in adults and children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.